Contrast-induced nephropathy in cardiology practice: Risk factors and approaches to prevention
https://doi.org/10.18705/1607-419X-2012-18-3-222-227
Abstract
Objective. To study the incidence and risk factors of contrast-induced nephropathy (CIN) resulted from percutaneous coronary interventions in cardiology practice. Design and methods. Retrospective analysis of 100 history cases of patients aged 37-73 years (mean age 56,1 ± 6,0 years) was preformed. 0mnipac-350 was used as a contrast agent during angiography. Glomerular filtration rate (GFR) was assessed by Cockroft-Gault formula before and 48 hours after the intervention. The patients were divided into 2 groups depending on the type of intervention: the first group included the patients with planned intervention and the second — with urgent endovascular intervention. Results. In the first group 3,0 % (n = 2) patients developed CIN, and one case was registered (2,95 %) in the second group. It developed in patients with initial decrease of GFR, in patients with diabetes mellitus and with the combination of both factors.
About the Authors
YU. F. Salakhova
Samara Regional Cardiology Specialized Clinic
Russian Federation
Russian Federation
D. V. Duplyakov
Samara Regional Cardiology Specialized Clinic; Samara State Medical University
Russian Federation
Russian Federation
E. R. Perunova
Samara Regional Cardiology Specialized Clinic
Russian Federation
Russian Federation
S. E. Burnazyan
Samara Regional Cardiology Specialized Clinic
Russian Federation
Russian Federation
E. I. Bazhenova
Samara Regional Cardiology Specialized Clinic
Russian Federation
Russian Federation
G. V. Kositsina
Samara Regional Cardiology Specialized Clinic
Russian Federation
Russian Federation
S. M. Khokhlunov
Samara Regional Cardiology Specialized Clinic; Samara State Medical University
Russian Federation
Russian Federation
References
1. European Society of Urogenital Radiology. Guidelines on Contrast Media, Version 5.0. — 2006. — [Электронный ресурс] (available at www.esur.org).
2. Nash K., Hafeez A., Hou S. Hospital-acquired renal insufficiency // Am. J. Kidney Dis. — 2002. — Vol. 39, № 5. — P. 930-936.
3. Rihal G.S., Textor S.C., Grill D.E. et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention // Circulation. — 2002. — Vol. 105, № 19. — Р. 2259-2264.
4. Weisbord S.D., Palevsky P.M. Prevention of contrast-induced nephropathy with volume expansion // Clin. J. Am. Soc. Nephrol. — 2008. — Vol. 3, № 1. — Р. 273-280.
5. McCullough P.A., Wolyn R., Rocher L.L., Levin R.N., O'Neill W.W. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality // Am. J. Med. — 1997. — Vol. 103, № 5. — P. 368-375.
6. Rich M.W., Crecelius C.A. Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. A prospective study // Arch. Int. Med. — 1990. — Vol. 150, № 6. — Р. 1237-1242.
7. Dangas G., Iakovou I., Nikolsky E. et al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables // Am. J. Card. — 2005. — Vol. 95, № 1. — P. 13-19.
8. Дундуа Д.П., Бабунашвили А.М., Карташов Д.С. и др. Сравнение рентгеноконтрастных препаратов по нефротоксичности: результаты рандомизированного исследования // Междунар. журн. интервенцион. кардиол. — 2010. — № 20. — С. 26-33.
9. Aspelin P., Aubry P., Fransson S.G., Strasser R., Wil-lenbrock R., Berg K.J. Nephrotoxic effects in high-risk patients undergoing angiography // N. Engl. J. Med. — 2003. — Vol. 348, № 6. — Р. 491-499.
10. Youn T.J., Koo B.K., Park J.S. et al. Renal toxicity evaluation and comparison between Visipaque (iodixanol) and Hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial // J. Am. Coll. Cardiol. — 2006. — Vol. 48, № 5. — P. 924-930.
11. Mehran R., Nikolsky E., Kirtane A.J. et al. The ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) Study // J. Am. Coll. Cardiol. Cardiovasc. Interv. — 2009. — Vol. 2, № 5. — P. 415-421.
12. Heyman S.N., Reichman J., Brezis M. Pathophysiology of radiocontrast nephropathy: a role for medullary hypoxia // Invest. Radiol. — 1999. — Vol. 34. — P. 685-691.
13. Barrett B.J., Parfrey P.S. Preventing nephropathy induced by contrast medium // N. Engl. J. Med. — 2006. — Vol. 354, № 4. — P. 379-386.
14. Каюков И.Г., Смирнов А.В., Добронравов В.А. Рент-генконтрастная нефропатия // Нефрология. — 2007. — Т. 11, № 3. — С. 93-104.
Review
For citations:
Salakhova Yu.F., Duplyakov D.V., Perunova E.R., Burnazyan S.E., Bazhenova E.I., Kositsina G.V., Khokhlunov S.M. Contrast-induced nephropathy in cardiology practice: Risk factors and approaches to prevention. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2012;18(3):222-227. (In Russ.) https://doi.org/10.18705/1607-419X-2012-18-3-222-227
Views:
955
Email this article 